...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Expectations for the AGM?
4
Dec 06, 2020 12:17PM
4
Dec 06, 2020 03:13PM
6
Dec 08, 2020 05:51PM
1
Dec 10, 2020 01:00PM
1
Dec 10, 2020 01:09PM
2
Dec 10, 2020 01:51PM

I'm sure Don is trying his best to get deals.  He's in his 60s I think so I suspect he'd like to cash out of both Zenith and RVX, the sooner the better.  I'm not expecting anything much to come from the Zenith AGM.  I'm afraid I'll start yawning if I hear anything that's excessively, inordinately, unrealistically optimistic.

3
Dec 10, 2020 02:55PM
Share
New Message
Please login to post a reply